Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient Outcome
AJANI, J. A, MANSFIELD, P. F, NIVERS, R, MORRIS, J, PISTERS, P. W, CRANE, C. H, WU, T. T, LUNAGOMEZ, S, LYNCH, P. M, JANJAN, N, FEIG, B, FAUST, J, YAO, J. C
Published in Journal of clinical oncology (20.02.2005)
Published in Journal of clinical oncology (20.02.2005)
Get full text
Journal Article
Pseudo-Lipschitz property of linear semi-infinite vector optimization problems
Chuong, T.D., Huy, N.Q., Yao, J.C.
Published in European journal of operational research (01.02.2010)
Published in European journal of operational research (01.02.2010)
Get full text
Journal Article
Radiation Therapy for High-Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal
Voong, K, Rashid, A, Crane, C.H, Minsky, B.D, Krishnan, S, Yao, J.C, Wolff, R.A, Skibber, J.M, Feig, B.W, Chang, G.J, Das, P
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
6573 POSTER Effect of Everolimus Treatment on Markers of Angiogenesis in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET) – Results From the Phase III RADIANT-3 Study
Yao, J.C, Tsuchihashi, Z, Panneerselvam, A, Winkler, R.E, Bugarini, R, Pavel, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
6566 POSTER Updated Safety and Efficacy Results From RADIANT-2 – a Randomized, Double-blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Pts With Advanced Neuroendocrine Tumours (NET)
Ricci, S, Ruszniewski, P, Tomasetti, P, Jehl, V, Saletan, S, Yao, J.C, Pavel, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
6564 POSTER Correlation of PFS With Early Response of Chromogranin A and 5-hydroxyindoleacetic Acid Levels in Pts With Advanced Neuroendocrine Tumours: Phase III RADIANT-2 Study Results
Baudin, E, Wolin, E, Castellano, D, Kaltsas, G, Panneerselvam, A, Tsuchihashi, Z, Saletan, S, Yao, J.C, Gross, D
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Degree theory for generalized variational inequalities and applications
Kien, B.T., Wong, M.-M., Wong, N.C., Yao, J.C.
Published in European journal of operational research (01.02.2009)
Published in European journal of operational research (01.02.2009)
Get full text
Journal Article
6561 POSTER Updated Survival and Safety Data From RADIANT-3 – a Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Trial of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET)
Lombard-Bohas, C, Van Cutsem, E, Capdevila, J, de Vries, E.G.E, Tomassetti, P, Lincy, J, Winkler, R.E, Hobday, T, Pommier, R, Yao, J.C
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
177 Lu-Dotatate améliore significativement la survie sans progression des patients atteints de tumeurs neuroendocrines métastatiques progressives de l’intestin moyen : résultats de l’essai de phase III NETTER-1
Ruszniewski, P, Courbon, F, Lebtahi, R, Giammarile, F, Lombard-Bohas, C, Ansquer, C, Matysiac, T, Guimbaud, R, Taieb, D, Seitz, J.F, Ducreux, M, Baudin, E, Yao, J.C, Hendifar, A, Krenning, E, Strosber, J
Published in Annales d'endocrinologie (01.09.2016)
Published in Annales d'endocrinologie (01.09.2016)
Get full text
Journal Article
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
Pavel, M.E., Baudin, E., Öberg, K.E., Hainsworth, J.D., Voi, M., Rouyrre, N., Peeters, M., Gross, D.J., Yao, J.C.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
Kulke, M.H., Ruszniewski, P., Van Cutsem, E., Lombard-Bohas, C., Valle, J.W., De Herder, W.W., Pavel, M., Degtyarev, E., Brase, J.C., Bubuteishvili-Pacaud, L., Voi, M., Salazar, R., Borbath, I., Fazio, N., Smith, D., Capdevila, J., Riechelmann, R.P., Yao, J.C.
Published in Annals of oncology (01.06.2017)
Published in Annals of oncology (01.06.2017)
Get full text
Journal Article
31P Effect of fruquintinib in patients with heavily pretreated metastatic colorectal cancer according to prognostic factors at baseline: Exploratory analysis of FRESCO-2
Tabernero, J., Eng, C., Lonardi, S., Elez Fernandez, M.E., Yoshino, T., Sobrero, A., Yao, J.C., Sartore Bianchi, A., Randrian, V., Cremolini, C., Ghiringhelli, F., Hochster, H., Kasper-Virchow, S., Van Cutsem, E., Arnold, D., Tougeron, D., Zhu, H., Dong, C., Carton, I., Dasari, N.A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
403MO Atezolizumab in combination with bevacizumab for patients with unresectable/metastatic anal cancer
Morris, V., Liu, S., Johnson, B., Prasad, S., Mahvash, A., Bhosale, P., Rubin, M.L., Rothschild, N., Futreal, A., Wistuba, I.I., Hwu, P., Yao, J.C., Eng, C., Halperin, D.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1102P The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
Ruszniewski, P.B., Caplin, M.E., Kunz, P.L., Bodei, L., Hendifar, A.E., Mittra, E., Wolin, E.M., Yao, J.C., Pavel, M.E., Grande, E., Van Cutsem, E., Seregni, E., Duarte, H., Demange, A., Mutevelic, S., Krenning, E.P., Strosberg, J.R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article